Fo
Non vérifié

Foundation Medicine

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueOncologieSanté
04/12/2025
Biotechnologie
Santé
Industrie pharmaceutique
Santé Publique
Science
Oncologie
Industrie
Foundation Medicine Achieves Historic Milestone of 100 Approved and Active Companion Diagnostic Indications, Solidifying Leadership in Precision Medicine
1.00
30/10/2025
Marché du travail
Industrie
Technique
Biotechnologie
Santé
Industrie pharmaceutique
Oncologie
Science
Technologies Diverses
Logiciels
Santé Publique
Technologies de l'Information
Foundation Medicine and Manifold Partner to Accelerate Drug Discovery and Development by Bringing AI-Enabled Analytics to FoundationInsights®
1.00
13/10/2025
Biotechnologie
Hygiène alimentaire
Santé
Santé Publique
Industrie pharmaceutique
Oncologie
Science
Médecine - Divers
Événements
Industrie
Foundation Medicine Spotlights Scientific Achievements Across its Portfolio of High-Quality Biomarker Tests at the 2025 European Society for Medical Oncology (ESMO) Congress
1.00
02/10/2025
Associations/Professionnels
Industrie pharmaceutique
Oncologie
Santé Publique
Santé
Vitrines/Shopping
Volontariat/Solidarité/Bénévolat
Foundation Medicine Awards the Improving Diagnostics Education and Awareness (IDEA) Program Grant to My Style Matters and H.Y.P.E. to Empower to Increase Biomarker Testing in Black, Latinx and LGBTQ+ Communities
1.00
23/09/2025
Industrie
Santé
Biotechnologie
Équipement médical et sanitaire
Oncologie
Foundation Medicine Launches Molecular Residual Disease (MRD) Test for Research Use in Early to Late-Stage Cancers Through its FlexOMx™ Lab
1.00
23/05/2025
Industrie
Santé
Biotechnologie
Équipement médical et sanitaire
Oncologie
Foundation Medicine Expands Immunohistochemistry (IHC) Testing Portfolio to Include MET IHC Testing
1.00
22/05/2025
Événements
Expos
Oncologie
Santé
Hygiène alimentaire
Santé Publique
Médecine - Divers
Industrie pharmaceutique
Biotechnologie
Foundation Medicine to Present Over 15 Abstracts at the 2025 ASCO® Annual Meeting
1.00
17/01/2025
Industrie
Biotechnologie
Hygiène alimentaire
Santé
Santé Publique
Industrie pharmaceutique
Oncologie
Science
Médecine - Divers
U.S. Food and Drug Administration Approves FoundationOne®CDx as a Companion Diagnostic for OJEMDA™ (tovorafenib) to Treat the Most Common Form of Childhood Brain Tumor in Pediatric Patients
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0